ArticleJAMA network open2022

Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease.

Nicolas Hoertel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.